Design and Synthesis of Hydroxyethylene-Based BACE-1 Inhibitors Incorporating Extended P1 Substituents
Authors:
- Marcus BäckMBMarcus Bäck
- Ingemar KvarnströmIKIngemar Kvarnström
- Anders DahlgrenADAnders Dahlgren
Open Access
- 8 March 2013
- journal article
- Published by Bentham Science Publishers Ltd. in The Open Medicinal Chemistry Journal
- Vol. 07 (1) , 01-15
Abstract
Novel BACE-1 inhibitors with a hydroxyethylene central core have been developed. Modified P1´ and extended P1 substituents were incorporated with the aim to explore potential interactions with the S1´ and the S1-S3 pocket, respectively, of BACE-1. Inhibitors were identified displaying IC 50 values in the nanomolar range, i.e. 69 nM for the most potent compound. Possible inhibitor interactions with the enzyme are also discussed.Keywords
This publication has 17 references indexed in Scilit:
- Structure-guided design and synthesis of position 1-phenylcycloalkylamine-derived pentapeptidic BACE1 inhibitorsBioorganic & Medicinal Chemistry, 2011
- Synthesis of potent BACE-1 inhibitors incorporating a hydroxyethylene isostere as central coreEuropean Journal of Medicinal Chemistry, 2010
- Design and Synthesis of Potent and Selective BACE-1 InhibitorsJournal of Medicinal Chemistry, 2010
- Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: Exploration of P1 phenoxy and benzyloxy residuesBioorganic & Medicinal Chemistry, 2008
- Therapies for Alzheimer's diseaseNature Reviews Drug Discovery, 2007
- Design and Synthesis of Potent Inhibitors of Plasmepsin I and II: X-ray Crystal Structure of Inhibitor in Complex with Plasmepsin IIJournal of Medicinal Chemistry, 2005
- Structure-Based Design of Potent and Selective Cell-Permeable Inhibitors of Human β-Secretase (BACE-1)Journal of Medicinal Chemistry, 2004
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeuticsHuman Molecular Genetics, 2001
- Structurally Altered Substrates for DNA Topoisomerase. I. Effects of Inclusion of a Single 3'-Deoxynucleotide Within the Scissile StrandNucleosides, Nucleotides & Nucleic Acids, 1998